(+)-schisandrin B multiple interactions EXP 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of PRKACA mRNA] CTD PMID:31150632 (1->4)-beta-D-glucan multiple interactions ISO Prkaca (Mus musculus) 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of PRKACA mRNA CTD PMID:36331819 1,1,1-Trichloro-2-(o-chlorophenyl)-2-(p-chlorophenyl)ethane increases activity ISO PRKACA (Homo sapiens) 6480464 o and p'-DDT results in increased activity of PRKACA protein CTD PMID:19526567 1,1,1-Trichloro-2-(o-chlorophenyl)-2-(p-chlorophenyl)ethane decreases activity EXP 6480464 o and p'-DDT results in decreased activity of PRKACA protein CTD PMID:23209616 1,2-dimethylhydrazine increases expression EXP 6480464 1 and 2-Dimethylhydrazine results in increased expression of PRKACA mRNA CTD PMID:27840820 14-Deoxy-11,12-didehydroandrographolide multiple interactions ISO Prkaca (Mus musculus) 6480464 14-deoxy-11 and 12-didehydroandrographolide inhibits the reaction [[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased phosphorylation of PRKACA protein] CTD PMID:30248417 17alpha-ethynylestradiol increases expression ISO Prkaca (Mus musculus) 6480464 Ethinyl Estradiol results in increased expression of PRKACA mRNA CTD PMID:17942748 17alpha-ethynylestradiol multiple interactions ISO PRKACA (Homo sapiens) 6480464 PRKACA protein affects the reaction [Ethinyl Estradiol results in decreased expression of ABCB11 mRNA] more ... CTD PMID:27743861 2,2',4,4'-Tetrabromodiphenyl ether decreases expression EXP 6480464 2 more ... CTD PMID:21394737 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO Prkaca (Mus musculus) 6480464 Tetrachlorodibenzodioxin results in increased expression of PRKACA mRNA CTD PMID:15667827 and PMID:17407152 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of PRKACA mRNA CTD PMID:33387578 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO Prkaca (Mus musculus) 6480464 Tetrachlorodibenzodioxin affects the expression of PRKACA mRNA CTD PMID:21570461 2-tert-butylhydroquinone increases expression ISO Prkaca (Mus musculus) 6480464 2-tert-butylhydroquinone results in increased expression of PRKACA mRNA CTD PMID:16014739 3,4-methylenedioxymethamphetamine increases expression ISO Prkaca (Mus musculus) 6480464 N-Methyl-3 and 4-methylenedioxyamphetamine results in increased expression of PRKACA mRNA CTD PMID:20188158 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO Prkaca (Mus musculus) 6480464 14-deoxy-11 more ... CTD PMID:29288687 and PMID:30248417 4,4'-diaminodiphenylmethane decreases expression ISO Prkaca (Mus musculus) 6480464 4 and 4'-diaminodiphenylmethane results in decreased expression of PRKACA mRNA CTD PMID:18648102 4,4'-sulfonyldiphenol multiple interactions EXP 6480464 [bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of PRKACA mRNA CTD PMID:36041667 4-aminopyridine increases phosphorylation EXP 6480464 4-Aminopyridine results in increased phosphorylation of PRKACA protein CTD PMID:35643327 4-aminopyridine multiple interactions EXP 6480464 lappaconitine inhibits the reaction [4-Aminopyridine results in increased phosphorylation of PRKACA protein] CTD PMID:35643327 6-propyl-2-thiouracil increases expression EXP 6480464 Propylthiouracil results in increased expression of PRKACA mRNA CTD PMID:30047161 amitrole increases expression EXP 6480464 Amitrole results in increased expression of PRKACA mRNA CTD PMID:30047161 ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of PRKACA mRNA CTD PMID:16483693 antimycin A decreases expression ISO PRKACA (Homo sapiens) 6480464 Antimycin A results in decreased expression of PRKACA mRNA CTD PMID:33512557 aristolochic acid A increases expression ISO PRKACA (Homo sapiens) 6480464 aristolochic acid I results in increased expression of PRKACA mRNA CTD PMID:33212167 arsenite(3-) increases expression ISO Prkaca (Mus musculus) 6480464 arsenite results in increased expression of PRKACA mRNA CTD PMID:18191166 asbestos affects expression ISO PRKACA (Homo sapiens) 6480464 Asbestos affects the expression of PRKACA mRNA CTD PMID:17297452 atorvastatin calcium multiple interactions EXP 6480464 Atorvastatin results in increased phosphorylation of and results in increased activity of PRKACA protein and N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide inhibits the reaction [Atorvastatin results in increased phosphorylation of and results in increased activity of PRKACA protein] CTD PMID:19053045 atrazine decreases expression EXP 6480464 Atrazine results in decreased expression of PRKACA mRNA and Atrazine results in decreased expression of PRKACA protein CTD PMID:30065202 BAPTA multiple interactions EXP 6480464 1 more ... CTD PMID:21863293 belinostat increases expression ISO PRKACA (Homo sapiens) 6480464 belinostat results in increased expression of PRKACA mRNA CTD PMID:26272509 belinostat multiple interactions ISO PRKACA (Homo sapiens) 6480464 [NOG protein co-treated with belinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PRKACA mRNA CTD PMID:27188386 benzo[a]pyrene affects methylation ISO PRKACA (Homo sapiens) 6480464 Benzo(a)pyrene affects the methylation of PRKACA intron and Benzo(a)pyrene affects the methylation of PRKACA promoter CTD PMID:27901495 and PMID:30157460 bis(2-ethylhexyl) phthalate decreases phosphorylation ISO Prkaca (Mus musculus) 6480464 Diethylhexyl Phthalate results in decreased phosphorylation of PRKACA protein CTD PMID:32303808 bis(2-ethylhexyl) phthalate multiple interactions ISO Prkaca (Mus musculus) 6480464 Diethylhexyl Phthalate promotes the reaction [[Streptozocin co-treated with Dietary Fats co-treated with Dietary Sugars] results in decreased phosphorylation of PRKACA protein] CTD PMID:32303808 bisphenol A multiple interactions EXP 6480464 [bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of PRKACA mRNA and [bisphenol A co-treated with Testosterone] results in increased expression of PRKACA mRNA CTD PMID:26496021 and PMID:36041667 bisphenol A affects expression ISO Prkaca (Mus musculus) 6480464 bisphenol A affects the expression of PRKACA mRNA CTD PMID:35341816 bisphenol A increases expression ISO PRKACA (Homo sapiens) 6480464 bisphenol A results in increased expression of PRKACA protein CTD PMID:34186270 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of PRKACA mRNA CTD PMID:30816183 and PMID:32528016 bisphenol A affects expression EXP 6480464 bisphenol A affects the expression of PRKACA mRNA CTD PMID:25181051 bisphenol A decreases expression ISO Prkaca (Mus musculus) 6480464 bisphenol A results in decreased expression of PRKACA mRNA CTD PMID:26063408 Bisphenol B increases expression ISO PRKACA (Homo sapiens) 6480464 bisphenol B results in increased expression of PRKACA protein CTD PMID:34186270 bisphenol F increases expression ISO PRKACA (Homo sapiens) 6480464 bisphenol F results in increased expression of PRKACA protein CTD PMID:34186270 bisphenol F multiple interactions EXP 6480464 [bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of PRKACA mRNA CTD PMID:36041667 bucladesine multiple interactions EXP 6480464 KT 5720 inhibits the reaction [Bucladesine results in increased activity of PRKACA protein] CTD PMID:31300867 bucladesine increases activity EXP 6480464 Bucladesine results in increased activity of PRKACA protein CTD PMID:31300867 buprenorphine decreases activity EXP 6480464 Buprenorphine results in decreased activity of PRKACA protein CTD PMID:24321744 buspirone decreases expression EXP 6480464 Buspirone results in decreased expression of PRKACA mRNA CTD PMID:24136188 cadmium atom decreases expression EXP 6480464 Cadmium results in decreased expression of PRKACA protein CTD PMID:25981801 cadmium atom multiple interactions ISO PRKACA (Homo sapiens) 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of PRKACA mRNA CTD PMID:35301059 cadmium dichloride decreases expression EXP 6480464 Cadmium Chloride results in decreased expression of PRKACA protein CTD PMID:25981801 and PMID:29214744 cadmium dichloride multiple interactions ISO PRKACA (Homo sapiens) 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of PRKACA mRNA CTD PMID:35301059 cadmium dichloride decreases expression ISO Prkaca (Mus musculus) 6480464 Cadmium Chloride results in decreased expression of PRKACA protein CTD PMID:31014900 cadmium dichloride multiple interactions ISO Prkaca (Mus musculus) 6480464 cyanidin-3-O-beta-glucopyranoside inhibits the reaction [Cadmium Chloride results in decreased expression of PRKACA protein] CTD PMID:31014900 caffeine decreases expression EXP 6480464 Caffeine results in decreased expression of PRKACA protein CTD PMID:30825513 caffeine decreases phosphorylation ISO PRKACA (Homo sapiens) 6480464 Caffeine results in decreased phosphorylation of PRKACA protein CTD PMID:35688186 caffeine decreases expression ISO PRKACA (Homo sapiens) 6480464 Caffeine results in decreased expression of PRKACA protein CTD PMID:30825513 cannabidiol affects methylation EXP 6480464 Cannabidiol affects the methylation of PRKACA gene CTD PMID:30521419 cannabidiol multiple interactions ISO PRKACA (Homo sapiens) 6480464 [Cannabidiol co-treated with moringin] results in decreased expression of PRKACA mRNA CTD PMID:30096889 capsaicin increases phosphorylation ISO Prkaca (Mus musculus) 6480464 Capsaicin results in increased phosphorylation of PRKACA protein CTD PMID:21908651 captopril multiple interactions EXP 6480464 Captopril inhibits the reaction [Pregabalin results in decreased expression of PRKACA protein] CTD PMID:31629013 CGP 52608 multiple interactions ISO PRKACA (Homo sapiens) 6480464 CGP 52608 promotes the reaction [RORA protein binds to PRKACA gene] CTD PMID:28238834 chaetocin multiple interactions EXP 6480464 chaetocin inhibits the reaction [Dronabinol results in decreased expression of PRKACA mRNA] CTD PMID:29022873 and PMID:29481316 chlorpyrifos decreases expression ISO Prkaca (Mus musculus) 6480464 Chlorpyrifos results in decreased expression of PRKACA mRNA CTD PMID:32715474 cisplatin multiple interactions ISO PRKACA (Homo sapiens) 6480464 [PRKACA results in increased phosphorylation of BAD protein] which results in decreased susceptibility to Cisplatin CTD PMID:21849418 cisplatin increases expression ISO PRKACA (Homo sapiens) 6480464 Cisplatin results in increased expression of PRKACA mRNA CTD PMID:27392435 cisplatin decreases expression ISO PRKACA (Homo sapiens) 6480464 Cisplatin results in decreased expression of PRKACA mRNA CTD PMID:27594783 clenbuterol multiple interactions EXP 6480464 Clenbuterol inhibits the reaction [Oxidopamine results in decreased phosphorylation of PRKACA protein] CTD PMID:16339297 clozapine increases expression EXP 6480464 Clozapine results in increased expression of PRKACA mRNA CTD PMID:15860345 cobalt dichloride decreases expression ISO PRKACA (Homo sapiens) 6480464 cobaltous chloride results in decreased expression of PRKACA mRNA CTD PMID:19320972 cocaine multiple interactions EXP 6480464 [Cocaine affects the activity of PRKACA protein] which affects the phosphorylation of DPYSL2 protein more ... CTD PMID:12595601 and PMID:19457111 cocaine affects expression EXP 6480464 Cocaine affects the expression of PRKACA protein CTD PMID:15659224 cocaine affects activity EXP 6480464 Cocaine affects the activity of PRKACA protein CTD PMID:19457111 colforsin daropate hydrochloride multiple interactions EXP 6480464 Colforsin inhibits the reaction [Oxidopamine results in decreased phosphorylation of PRKACA protein] CTD PMID:16339297 colforsin daropate hydrochloride increases activity ISO PRKACA (Homo sapiens) 6480464 Colforsin results in increased activity of PRKACA protein CTD PMID:28601556 copper(II) sulfate decreases expression ISO Prkaca (Mus musculus) 6480464 Copper Sulfate results in decreased expression of PRKACA mRNA and Copper Sulfate results in decreased expression of PRKACA protein CTD PMID:37353053 copper(II) sulfate multiple interactions ISO Prkaca (Mus musculus) 6480464 N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide promotes the reaction [Copper Sulfate results in decreased expression of PRKACA mRNA] more ... CTD PMID:37353053 daidzein multiple interactions ISO PRKACA (Homo sapiens) 6480464 [daidzein co-treated with daidzin co-treated with genistin co-treated with Genistein co-treated with glycitin co-treated with glycitein] results in decreased expression of PRKACA mRNA CTD PMID:27424125 daidzein 7-O-beta-D-glucoside multiple interactions ISO PRKACA (Homo sapiens) 6480464 [daidzein co-treated with daidzin co-treated with genistin co-treated with Genistein co-treated with glycitin co-treated with glycitein] results in decreased expression of PRKACA mRNA CTD PMID:27424125 deguelin decreases expression ISO PRKACA (Homo sapiens) 6480464 deguelin results in decreased expression of PRKACA mRNA CTD PMID:33512557 dexamethasone multiple interactions ISO Prkaca (Mus musculus) 6480464 14-deoxy-11 more ... CTD PMID:29288687 and PMID:30248417 dibutyl phthalate decreases expression ISO Prkaca (Mus musculus) 6480464 Dibutyl Phthalate results in decreased expression of PRKACA protein CTD PMID:36602389 dicrotophos increases expression ISO PRKACA (Homo sapiens) 6480464 dicrotophos results in increased expression of PRKACA mRNA CTD PMID:28302478 dobutamine multiple interactions EXP 6480464 Dobutamine inhibits the reaction [Oxidopamine results in decreased phosphorylation of PRKACA protein] CTD PMID:16339297 Doramectin decreases expression EXP 6480464 doramectin results in decreased expression of PRKACA mRNA CTD PMID:35137919 dorsomorphin multiple interactions ISO PRKACA (Homo sapiens) 6480464 [NOG protein co-treated with belinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 doxorubicin increases expression ISO PRKACA (Homo sapiens) 6480464 Doxorubicin results in increased expression of PRKACA mRNA CTD PMID:16404146 epoxiconazole decreases expression ISO Prkaca (Mus musculus) 6480464 epoxiconazole results in decreased expression of PRKACA mRNA CTD PMID:35436446 ethanol decreases expression EXP 6480464 Ethanol results in decreased expression of PRKACA mRNA CTD PMID:20655511 ethanol multiple interactions ISO Prkaca (Mus musculus) 6480464 Ethanol affects the expression of and affects the splicing of PRKACA mRNA CTD PMID:30319688 ethyl methanesulfonate increases expression ISO PRKACA (Homo sapiens) 6480464 Ethyl Methanesulfonate results in increased expression of PRKACA mRNA CTD PMID:23649840 fluoranthene multiple interactions ISO Prkaca (Mus musculus) 6480464 [1-methylanthracene co-treated with fluoranthene] results in decreased expression of PRKACA mRNA CTD PMID:28329830 formaldehyde increases expression ISO PRKACA (Homo sapiens) 6480464 Formaldehyde results in increased expression of PRKACA mRNA CTD PMID:23649840 FR900359 increases phosphorylation ISO PRKACA (Homo sapiens) 6480464 FR900359 results in increased phosphorylation of PRKACA protein CTD PMID:37730182 genistein multiple interactions ISO PRKACA (Homo sapiens) 6480464 [daidzein co-treated with daidzin co-treated with genistin co-treated with Genistein co-treated with glycitin co-treated with glycitein] results in decreased expression of PRKACA mRNA CTD PMID:27424125 genistein 7-O-beta-D-glucoside multiple interactions ISO PRKACA (Homo sapiens) 6480464 [daidzein co-treated with daidzin co-treated with genistin co-treated with Genistein co-treated with glycitin co-treated with glycitein] results in decreased expression of PRKACA mRNA CTD PMID:27424125 gentamycin decreases expression EXP 6480464 Gentamicins results in decreased expression of PRKACA mRNA CTD PMID:33387578 glycitein multiple interactions ISO PRKACA (Homo sapiens) 6480464 [daidzein co-treated with daidzin co-treated with genistin co-treated with Genistein co-treated with glycitin co-treated with glycitein] results in decreased expression of PRKACA mRNA CTD PMID:27424125 glycitin multiple interactions ISO PRKACA (Homo sapiens) 6480464 [daidzein co-treated with daidzin co-treated with genistin co-treated with Genistein co-treated with glycitin co-treated with glycitein] results in decreased expression of PRKACA mRNA CTD PMID:27424125 glyphosate decreases expression ISO PRKACA (Homo sapiens) 6480464 Glyphosate results in decreased expression of PRKACA mRNA CTD PMID:31295307 haloperidol increases expression EXP 6480464 Haloperidol results in increased expression of PRKACA mRNA CTD PMID:15860345 hydrogen peroxide multiple interactions ISO PRKACA (Homo sapiens) 6480464 [Hydrogen Peroxide co-treated with Theophylline] results in decreased expression of PRKACA protein CTD PMID:18951874 hydrogen sulfide increases phosphorylation ISO Prkaca (Mus musculus) 6480464 Hydrogen Sulfide results in increased phosphorylation of PRKACA protein CTD PMID:31843631 hydroxysafflor yellow A multiple interactions EXP 6480464 hydroxysafflor yellow A inhibits the reaction [2-chloro-5-nitrobenzanilide promotes the reaction [Particulate Matter results in decreased activity of PRKACA protein]] more ... CTD PMID:24192212 isoprenaline multiple interactions EXP 6480464 [Isoproterenol co-treated with POSTN protein] results in decreased expression of PRKACA mRNA CTD PMID:30303030 ivermectin decreases expression ISO PRKACA (Homo sapiens) 6480464 Ivermectin results in decreased expression of PRKACA protein CTD PMID:32959892 JTE-013 multiple interactions EXP 6480464 JTE 013 inhibits the reaction [Taurolithocholic Acid results in increased activity of PRKACA protein] CTD PMID:31300867 KT 5720 multiple interactions EXP 6480464 KT 5720 inhibits the reaction [Bucladesine results in increased activity of PRKACA protein] and KT 5720 inhibits the reaction [Taurolithocholic Acid results in increased activity of PRKACA protein] CTD PMID:31300867 Lappaconitine multiple interactions EXP 6480464 lappaconitine inhibits the reaction [4-Aminopyridine results in increased phosphorylation of PRKACA protein] CTD PMID:35643327 lead diacetate decreases expression EXP 6480464 lead acetate results in decreased expression of PRKACA protein CTD PMID:25981801 lead(0) decreases expression EXP 6480464 Lead results in decreased expression of PRKACA protein CTD PMID:25981801 Licarin A multiple interactions ISO Prkaca (Mus musculus) 6480464 PRKACA protein promotes the reaction [[licarin A affects the susceptibility to [INS protein co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone]] which results in increased expression of LIPE protein modified form] more ... CTD PMID:29288687 maneb multiple interactions EXP 6480464 [Paraquat co-treated with Maneb] results in decreased expression of PRKACA mRNA more ... CTD PMID:27460631 and PMID:33368748 manganese atom decreases expression EXP 6480464 Manganese results in decreased expression of PRKACA protein CTD PMID:25981801 manganese atom multiple interactions EXP 6480464 [manganese chloride results in increased abundance of Manganese] which results in increased activity of PRKACA protein CTD PMID:30951808 manganese(0) decreases expression EXP 6480464 Manganese results in decreased expression of PRKACA protein CTD PMID:25981801 manganese(0) multiple interactions EXP 6480464 [manganese chloride results in increased abundance of Manganese] which results in increased activity of PRKACA protein CTD PMID:30951808 manganese(II) chloride decreases expression EXP 6480464 manganese chloride results in decreased expression of PRKACA protein CTD PMID:25981801 manganese(II) chloride multiple interactions EXP 6480464 [manganese chloride results in increased abundance of Manganese] which results in increased activity of PRKACA protein CTD PMID:30951808 mercury dibromide increases expression ISO PRKACA (Homo sapiens) 6480464 mercuric bromide results in increased expression of PRKACA mRNA CTD PMID:26272509 mercury dibromide multiple interactions ISO PRKACA (Homo sapiens) 6480464 [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PRKACA mRNA CTD PMID:27188386 methidathion decreases expression ISO Prkaca (Mus musculus) 6480464 methidathion results in decreased expression of PRKACA mRNA CTD PMID:34813904 methylmercury chloride increases expression EXP 6480464 methylmercuric chloride results in increased expression of PRKACA protein CTD PMID:29258870 mono(2-ethylhexyl) phthalate increases expression ISO Prkaca (Mus musculus) 6480464 mono-(2-ethylhexyl)phthalate results in increased expression of PRKACA mRNA CTD PMID:25543134 N,N-diethyl-m-toluamide multiple interactions EXP 6480464 [Pyridostigmine Bromide co-treated with DEET co-treated with Permethrin] results in increased expression of PRKACA mRNA CTD PMID:28659758 N-[2-(4-bromocinnamylamino)ethyl]isoquinoline-5-sulfonamide multiple interactions EXP 6480464 N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide inhibits the reaction [Atorvastatin results in increased phosphorylation of and results in increased activity of PRKACA protein] CTD PMID:19053045 N-[2-(4-bromocinnamylamino)ethyl]isoquinoline-5-sulfonamide multiple interactions ISO Prkaca (Mus musculus) 6480464 N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide promotes the reaction [Copper Sulfate results in decreased expression of PRKACA mRNA] and N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide promotes the reaction [Copper Sulfate results in decreased expression of PRKACA protein] CTD PMID:37353053 N-methyl-4-phenylpyridinium affects expression ISO PRKACA (Homo sapiens) 6480464 1-Methyl-4-phenylpyridinium affects the expression of PRKACA mRNA CTD PMID:12710931 N-nitrosodiethylamine multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with caffeic acid phenethyl ester] results in decreased expression of PRKACA mRNA CTD PMID:20360939 N-nitrosodiethylamine increases expression EXP 6480464 Diethylnitrosamine results in increased expression of PRKACA protein CTD PMID:29698782 nefazodone decreases expression EXP 6480464 nefazodone results in decreased expression of PRKACA mRNA CTD PMID:24136188 Nor-9-carboxy-delta9-THC multiple interactions ISO PRKACA (Homo sapiens) 6480464 [Cannabinoids results in increased abundance of 11-nor-delta(9)-tetrahydrocannabinol-9-carboxylic acid] which affects the methylation of PRKACA gene CTD PMID:30521419 ochratoxin A increases acetylation ISO PRKACA (Homo sapiens) 6480464 ochratoxin A results in increased acetylation of PRKACA promoter CTD PMID:29098329 ochratoxin A multiple interactions ISO PRKACA (Homo sapiens) 6480464 [ochratoxin A results in increased acetylation of PRKACA promoter] which results in increased expression of PRKACA mRNA CTD PMID:29098329 ochratoxin A increases expression ISO PRKACA (Homo sapiens) 6480464 ochratoxin A results in increased expression of PRKACA mRNA CTD PMID:29098329 oxidopamine decreases phosphorylation EXP 6480464 Oxidopamine results in decreased phosphorylation of PRKACA protein CTD PMID:16339297 oxidopamine multiple interactions EXP 6480464 Clenbuterol inhibits the reaction [Oxidopamine results in decreased phosphorylation of PRKACA protein] more ... CTD PMID:16339297 oxycodone increases phosphorylation EXP 6480464 Oxycodone results in increased phosphorylation of PRKACA protein CTD PMID:26377394 ozone multiple interactions ISO PRKACA (Homo sapiens) 6480464 [Air Pollutants results in increased abundance of Ozone] which affects the expression of PRKACA mRNA CTD PMID:35430440 panobinostat multiple interactions ISO PRKACA (Homo sapiens) 6480464 [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PRKACA mRNA CTD PMID:27188386 panobinostat increases expression ISO PRKACA (Homo sapiens) 6480464 panobinostat results in increased expression of PRKACA mRNA CTD PMID:26272509 paracetamol increases expression ISO PRKACA (Homo sapiens) 6480464 Acetaminophen results in increased expression of PRKACA mRNA CTD PMID:25704631 paraquat multiple interactions EXP 6480464 [Paraquat co-treated with Maneb] results in decreased expression of PRKACA mRNA more ... CTD PMID:27460631 and PMID:33368748 perfluorooctane-1-sulfonic acid multiple interactions ISO Prkaca (Mus musculus) 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of PRKACA mRNA CTD PMID:36331819 perfluorooctanoic acid decreases expression EXP 6480464 perfluorooctanoic acid results in decreased expression of PRKACA mRNA CTD PMID:19162173 permethrin multiple interactions EXP 6480464 [Pyridostigmine Bromide co-treated with DEET co-treated with Permethrin] results in increased expression of PRKACA mRNA CTD PMID:28659758 phenethyl caffeate multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with caffeic acid phenethyl ester] results in decreased expression of PRKACA mRNA CTD PMID:20360939 phenobarbital affects expression ISO Prkaca (Mus musculus) 6480464 Phenobarbital affects the expression of PRKACA mRNA CTD PMID:23091169 phenylmercury acetate increases expression ISO PRKACA (Homo sapiens) 6480464 Phenylmercuric Acetate results in increased expression of PRKACA mRNA CTD PMID:26272509 phenylmercury acetate multiple interactions ISO PRKACA (Homo sapiens) 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PRKACA mRNA CTD PMID:27188386 pirinixic acid decreases expression EXP 6480464 pirinixic acid results in decreased expression of PRKACA mRNA CTD PMID:19162173 pregabalin multiple interactions EXP 6480464 Captopril inhibits the reaction [Pregabalin results in decreased expression of PRKACA protein] and Telmisartan inhibits the reaction [Pregabalin results in decreased expression of PRKACA protein] CTD PMID:31629013 pregabalin decreases expression EXP 6480464 Pregabalin results in decreased expression of PRKACA protein CTD PMID:31629013 propiconazole increases expression EXP 6480464 propiconazole results in increased expression of PRKACA mRNA CTD PMID:30047161 prostaglandin E2 multiple interactions ISO PRKACA (Homo sapiens) 6480464 [Dinoprostone co-treated with PTGER1 protein] results in increased phosphorylation of PRKACA protein CTD PMID:22188298 Pyridostigmine bromide multiple interactions EXP 6480464 [Pyridostigmine Bromide co-treated with DEET co-treated with Permethrin] results in increased expression of PRKACA mRNA CTD PMID:28659758 pyrimidifen decreases expression ISO PRKACA (Homo sapiens) 6480464 pyrimidifen results in decreased expression of PRKACA mRNA CTD PMID:33512557 quercetin multiple interactions EXP 6480464 PRKACA protein affects the reaction [Quercetin results in increased expression of EGR1 mRNA] and PRKACA protein affects the reaction [Quercetin results in increased expression of EGR1 protein] CTD PMID:22174042 reserpine decreases expression ISO Prkaca (Mus musculus) 6480464 Reserpine results in decreased expression of PRKACA protein CTD PMID:26114099 resveratrol multiple interactions ISO PRKACA (Homo sapiens) 6480464 [TNF protein co-treated with Resveratrol] results in increased expression of PRKACA protein more ... CTD PMID:24145604 and PMID:25943029 roflumilast multiple interactions EXP 6480464 Roflumilast inhibits the reaction [Rotenone results in decreased expression of PRKACA protein] CTD PMID:36706892 rotenone decreases expression EXP 6480464 Rotenone results in decreased expression of PRKACA mRNA and Rotenone results in decreased expression of PRKACA protein CTD PMID:28374803 and PMID:36706892 rotenone multiple interactions EXP 6480464 Roflumilast inhibits the reaction [Rotenone results in decreased expression of PRKACA protein] CTD PMID:36706892 rotenone decreases expression ISO PRKACA (Homo sapiens) 6480464 Rotenone results in decreased expression of PRKACA mRNA CTD PMID:33512557 SB 431542 multiple interactions ISO PRKACA (Homo sapiens) 6480464 [NOG protein co-treated with belinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 serpentine asbestos decreases methylation ISO PRKACA (Homo sapiens) 6480464 Asbestos and Serpentine results in decreased methylation of PRKACA 3' UTR CTD PMID:29523930 sodium arsenite decreases expression ISO PRKACA (Homo sapiens) 6480464 sodium arsenite results in decreased expression of PRKACA mRNA CTD PMID:12760830 sodium arsenite increases expression ISO PRKACA (Homo sapiens) 6480464 sodium arsenite results in increased expression of PRKACA mRNA CTD PMID:34032870 sodium arsenite increases expression ISO Prkaca (Mus musculus) 6480464 sodium arsenite results in increased expression of PRKACA mRNA CTD PMID:16014739 sodium fluoride increases expression ISO Prkaca (Mus musculus) 6480464 Sodium Fluoride results in increased expression of PRKACA protein CTD PMID:28918527 streptozocin multiple interactions ISO Prkaca (Mus musculus) 6480464 [Streptozocin co-treated with Dietary Fats co-treated with Dietary Sugars] results in decreased phosphorylation of PRKACA protein and Diethylhexyl Phthalate promotes the reaction [[Streptozocin co-treated with Dietary Fats co-treated with Dietary Sugars] results in decreased phosphorylation of PRKACA protein] CTD PMID:32303808 sulfadimethoxine increases expression EXP 6480464 Sulfadimethoxine results in increased expression of PRKACA mRNA CTD PMID:30047161 sulindac multiple interactions EXP 6480464 [Sulindac co-treated with lipopolysaccharide and E coli O55-B5] affects the expression of PRKACA mRNA CTD PMID:20371263 sulindac sulfide increases expression ISO PRKACA (Homo sapiens) 6480464 sulindac sulfide results in increased expression of PRKACA mRNA CTD PMID:16184548 sunitinib decreases expression ISO PRKACA (Homo sapiens) 6480464 Sunitinib results in decreased expression of PRKACA mRNA CTD PMID:31533062 tamibarotene increases expression ISO PRKACA (Homo sapiens) 6480464 tamibarotene results in increased expression of PRKACA mRNA CTD PMID:17229644 taurine multiple interactions EXP 6480464 Taurine inhibits the reaction [[Paraquat co-treated with Maneb] results in decreased expression of PRKACA mRNA] CTD PMID:33368748 taurolithocholic acid increases activity EXP 6480464 Taurolithocholic Acid results in increased activity of PRKACA protein CTD PMID:31300867 taurolithocholic acid multiple interactions EXP 6480464 JTE 013 inhibits the reaction [Taurolithocholic Acid results in increased activity of PRKACA protein] more ... CTD PMID:31300867 tebufenpyrad decreases expression ISO PRKACA (Homo sapiens) 6480464 4-chloro-N-((4-(1 and 1-dimethylethyl)phenyl)methyl)-3-ethyl-1-methyl-1H-pyrazole-5-carboxamide results in decreased expression of PRKACA mRNA CTD PMID:33512557 telmisartan multiple interactions EXP 6480464 Telmisartan inhibits the reaction [Pregabalin results in decreased expression of PRKACA protein] CTD PMID:31629013 testosterone multiple interactions EXP 6480464 [bisphenol A co-treated with Testosterone] results in increased expression of PRKACA mRNA CTD PMID:26496021 tetrachloromethane decreases expression EXP 6480464 Carbon Tetrachloride results in decreased expression of PRKACA mRNA CTD PMID:31150632 tetrachloromethane decreases expression ISO Prkaca (Mus musculus) 6480464 Carbon Tetrachloride results in decreased expression of PRKACA mRNA CTD PMID:31919559 tetrachloromethane multiple interactions EXP 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of PRKACA mRNA] CTD PMID:31150632 thapsigargin decreases expression EXP 6480464 Thapsigargin results in decreased expression of PRKACA protein CTD PMID:35544339 theophylline multiple interactions ISO PRKACA (Homo sapiens) 6480464 [Hydrogen Peroxide co-treated with Theophylline] results in decreased expression of PRKACA protein CTD PMID:18951874 thioacetamide decreases expression EXP 6480464 Thioacetamide results in decreased expression of PRKACA mRNA CTD PMID:23411599 trichloroethene decreases expression EXP 6480464 Trichloroethylene results in decreased expression of PRKACA mRNA CTD PMID:19448997 and PMID:33387578 triclosan increases expression EXP 6480464 Triclosan results in increased expression of PRKACA mRNA CTD PMID:30447264 Triptolide increases expression EXP 6480464 triptolide results in increased expression of PRKACA mRNA CTD PMID:23639586 Tylophorine increases expression ISO PRKACA (Homo sapiens) 6480464 tylophorine analog results in increased expression of PRKACA mRNA CTD PMID:19284764 urethane increases expression ISO PRKACA (Homo sapiens) 6480464 Urethane results in increased expression of PRKACA mRNA CTD PMID:28818685 valproic acid increases methylation ISO PRKACA (Homo sapiens) 6480464 Valproic Acid results in increased methylation of PRKACA gene CTD PMID:29154799 valproic acid increases expression EXP 6480464 Valproic Acid results in increased expression of PRKACA mRNA CTD PMID:32428529 valproic acid increases expression ISO PRKACA (Homo sapiens) 6480464 Valproic Acid results in increased expression of PRKACA mRNA CTD PMID:23179753 vanadium atom decreases expression ISO PRKACA (Homo sapiens) 6480464 Vanadium results in decreased expression of PRKACA mRNA CTD PMID:19000753 vanadium(0) decreases expression ISO PRKACA (Homo sapiens) 6480464 Vanadium results in decreased expression of PRKACA mRNA CTD PMID:19000753 vismodegib increases expression ISO PRKACA (Homo sapiens) 150573695 vismodegib increases protein kinase A protein expression in pituitary adenoma cells RGD